drugset / Trial / NCT05382832
Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial
Unknown
50 enrolled
EPC Education s.r.o.
National Hospital for Neurology and Neurosurgery, London · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The clinical trial is focused on the treatment of selected patients with a migraine after implantation of spinal cord stimulator (SCS) based on previous neurological examination. Patients will be randomized and divided into two groups. According to randomization patients will receive saline or botox into the epidural space. The efficacy of treatment will be compared and estimated in both groups during different SCS settings. Data will be collected in pre-set time frames.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2022-08-01
- Completion
- 2025-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Other |